Stroke
.
2021 Dec;52(12):4021-4032.
doi: 10.1161/STROKEAHA.120.033285. Epub 2021 Nov 1.
CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage
Jun Yan # 1, Weilin Xu # 2, Cameron Lenahan 3, Lei Huang 4 5, Jing Wen 6, Gaigai Li 7, Xin Hu 8, Wen Zheng 9, John H Zhang 4 5 10, Jiping Tang 5
Affiliations expand
PMID: 34719258
PMCID: PMC8607924
DOI: 10.1161/STROKEAHA.120.033285
Erratum in
Correction to: CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage.
[No authors listed]Stroke. 2024 Jul;55(7):e232. doi: 10.1161/STR.0000000000000467. Epub 2024 Jun 24.PMID: 38913804 No abstract available.
Abstract
Background and purpose: Neuronal pyroptosis is a type of regulated cell death triggered by proinflammatory signals. CCR5 (C-C chemokine receptor 5)-mediated inflammation is involved in the pathology of various neurological diseases. This study investigated the impact of CCR5 activation on neuronal pyroptosis and the underlying mechanism involving cAMP-dependent PKA (protein kinase A)/CREB (cAMP response element binding)/NLRP1 (nucleotide-binding domain leucine-rich repeat pyrin domain containing 1) pathway after experimental intracerebral hemorrhage (ICH).
Methods: A total of 194 adult male CD1 mice were used. ICH was induced by autologous whole blood injection. Maraviroc (MVC)-a selective antagonist of CCR5-was administered intranasally 1 hour after ICH. To elucidate the underlying mechanism, a specific CREB inhibitor, 666-15, was administered intracerebroventricularly before MVC administration in ICH mice. In a set of naive mice, rCCL5 (recombinant chemokine ligand 5) and selective PKA activator, 8-Bromo-cAMP, were administered intracerebroventricularly. Short- and long-term neurobehavioral assessments, Western blot, Fluoro-Jade C, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and immunofluorescence staining were performed.
Results: The brain expression of CCL5 (chemokine ligand 5), CCR5, PKA-Cα (protein kinase A-Cα), p-CREB (phospho-cAMP response element binding), and NLRP1 was increased, peaking at 24 hours after ICH. CCR5 was expressed on neurons, microglia, and astrocytes. MVC improved the short- and long-term neurobehavioral deficits and decreased neuronal pyroptosis in ipsilateral brain tissues at 24 hours after ICH, which were accompanied by increased PKA-Cα and p-CREB expression, and decreased expression of NLRP1, ASC (apoptosis-associated speck-like protein containing a CARD), C-caspase-1, GSDMD (gasdermin D), and IL (interleukin)-1β/IL-18. Such effects of MVC were abolished by 666-15. At 24 hours after injection in naive mice, rCCL5 induced neurological deficits, decreased PKA-Cα and p-CREB expression in the brain, and upregulated NLRP1, ASC, C-caspase-1, N-GSDMD, and IL-1β/IL-18 expression. Those effects of rCCL5 were reversed by 8-Bromo-cAMP.
Conclusions: CCR5 activation promoted neuronal pyroptosis and neurological deficits after ICH in mice, partially through the CCR5/PKA/CREB/NLRP1 signaling pathway. CCR5 inhibition with MVC may provide a promising therapeutic approach in managing patients with ICH.
Keywords: cerebral hemorrhage; chemokine receptor; inflammasome; neuron; pyroptosis.
参考链接:https://pubpeer.com/publications/5AF4D4F47122EBA4C302FE61B42D61
本文为【丰倍SCI】公众号原创文章
未经授权禁止转载!
转载请勿更改原文内容及格式!
如有转载需求或合作事宜
可添加下方客服微信
或后台私信小编
三重保障:Al查重+机械物理查重+人工查重
官网:www.fengbei-ai.com
客服微信:sindy01010101